Skip to content

Clinical trials

Completed Phase 3 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 3 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20091
20112
20131
20172
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Duke University2
Alexandria University1
Assistance Publique - Hôpitaux de Paris1
Fernando J Martinez1
Joe Chan1
The University of Texas Health Science Center, Houston1
University Hospital, Tours1
Zambon SpA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis11
Idiopathic Pulmonary Fibrosis4
Lung Diseases, Interstitial2
Scleroderma, Systemic2
COVID-191
Connective Tissue Diseases1
Cytokine Release Syndrome1
Hypertension, Pulmonary1
Inflammation1
Lung Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.